241
Views
12
CrossRef citations to date
0
Altmetric
Original Research

COVID-19 Vaccine Acceptance and its Predictors among College Students in Addis Ababa, Ethiopia, 2021: A Cross-Sectional Survey

ORCID Icon, , &
Pages 255-263 | Published online: 01 Feb 2022

Abstract

Background

The coronavirus disease pandemic disrupted the normal social and economic activities of the people resulting in over 3 million deaths worldwide. Piece of literature depicted that predictors of vaccine acceptance are complex, multiple, and vary depending on the type of vaccine involved.

Objective

The study aimed at assessing the COVID-19 acceptance and its predictors among college students in Addis Ababa, Ethiopia, 2021.

Methods

A multi-center-institutional-based cross-sectional study was conducted among 407 participants from three institutions in Addis Ababa selected based on a simple random sampling method from May 01 to July 30, 2021. A self-administered structured questionnaire was used for the collection of data, after which informed consent was obtained from all the included study participants. Descriptive statistics was used for the summarization of the data. Binary (bivariate and multivariate) logistic regression was applied for the identification predictors of vaccine acceptance with their respective 95% confidence interval and less than 5% p-value for the ascertainment of presence of association.

Results

The level of vaccine acceptance was 39.8% (95% CI: 35.0–44.7%). Being male (AOR: 0.463, 95% CI: 0.284–0.755, P < 0.001), living with children under the age of five (AOR: 2.295; 95% CI: 1.416–3.721, P < 0.05), living with an elderly (AOR: 1.609, 95% CI: 1.016–2.548, P < 0.05) and having had poor knowledge (AOR: 2.187, 95% CI: 1.391–3.438, P < 0.001) were predictors significantly associated with an increased level of vaccine acceptance.

Conclusion and Recommendation

The level of vaccine acceptance among college students in Ethiopia was lower than necessary to achieve herd immunity. Sex, living with under-five children, and elderly, and knowledge were predictors of COVID-19 acceptance. Concerned bodies were suggested to work over the identified predictors of vaccine acceptance in the study settings.

Introduction

The Coronavirus disease (COVID-19) pandemic disrupted the normal social and economic activities of the worldCitation1Citation5 and continued to havoc the globe.Citation5 However, the African continent recorded fewer proportion of the COVID-19 infection; the disease caused over 3 million deaths worldwide.Citation6

Numerous biologic and chemotherapeutic therapies such as convalescent plasma, tocilizumab, remdesivir and hydroxylchloroquine were applied for the treatment of COVID-19 patientsCitation7,Citation8 with no conclusive evidence on its cure rate.

Nevertheless, it was a recent experience that most of the world practiced different public health measures, such as social distancing, lockdowns, respiratory hygiene, and hand hygiene for the prevention of COVID-19 disease, a little role was recorded;Citation9 rather, an effective vaccine as a standing solution was recommended during the crises.Citation10,Citation11

Vaccine hesitancy is a delay in acceptance or refusal of vaccine despite the availability of vaccination service.Citation12 When safe and efficacious vaccines become available, governors could ensure a successful, large-scale uptake of COVID-19 vaccines to the attainment of community immunization.

Existing studies on COVID-19 vaccine uptake revealed that a considerable proportion of people are careless of taking the vaccine. A representative study from 19 countries revealed, 71.5% were likely to take the COVID-19 vaccine.Citation13 Perhaps; the evidence from 20 nations representative studies revealed the level of COVID-19 acceptance to be under 67%.Citation14

The predictors of vaccine acceptance are complex, multiple, and vary depending on the type of vaccine involved.Citation15Citation17 The level of trustworthiness of the source information determines the likelihood of vaccine acceptance,Citation18 but trust in COVID-19 vaccination varies widely between different groups of people.Citation19 It is reasonable to think more people trust vaccines, the more they will take the COVID-19 vaccine. However, the infodemic that inundated the world during the COVID-19 has changed vaccine acceptance,Citation20Citation23 – which directly shows that media sensationalism is linked to distrust in COVID and COVID-19 vaccines appear to have different predictors of acceptance than previous vaccine.Citation24

To the best knowledge of the researchers, there was a limited evidence regarding the acceptance of COVID-19 vaccine by college students in Ethiopia. Informed by the above statement, this study assessed the acceptance and predictors of COVID-19 vaccine by college students in Addis Ababa, Ethiopia.

Methods

Participants and Study Design

A multi-center-institutional-based cross-sectional study design was conducted among 407 participants from the selected colleges in Addis Ababa from May 01 to July 30, 2021. The study received ethical approval from Universal Medical and Business College, a research review ethics committee and applied to the respective colleges. All the participants were provided written informed consent. The source population was all regular students of the selected colleges; namely, Universal Medical and Business College, Kea Med Medical and Business College, and Africa Health Science College. The study population was all the 407 participants from the selected colleges available during the study period. Students who registered in the stated colleges, available during data collection, and those free from severe medical conditions were included in the study. A simple random sampling technique was employed to select the participants after their lists were once identified from the registrar of the respective colleges.

The sample size was determined based on a single population proportion, with the premise that the magnitude of vaccine acceptance among college students taken at 50%, since there was no prior study among the particular study group, 95% confidence interval 1.96 and 5% margin of error. The final sample was 422 inclusive of a 10% non-response rate.

Data were gathered with a pre-tested self-administered questionnaire. The questionnaire was developed by reviewing related pieces of literatureCitation25Citation29 then given to three senior researchers working in academic institutions, and their inputs were incorporated in the final tool.

Definitions of Concepts

The outcome variable (COVID-19 vaccine acceptance) was measured as yes and no question.Citation1,Citation27 Knowledge was measured as true and false questions and categorized as poor versus good knowledge based on median score after constructs forming knowledge were once computed.

Statistical Analysis

Descriptive statistics were used for the summarization of data. For the identification predictors of COVID-19 acceptance, binary (bi-variable and multivariable) logistic regression was used, with their respective 95% Confidence Interval (CI) and p-value of less than 0.05 as a statistically significant level.

Result

Socio-Demographic Characteristics

Of 422 students approached, 407 respondents completed the questionnaire, with a response rate of 96%. The majority (82.8%) and (68%) of the participants were single and females consecutively. The mean age of the participants was 21.9 years with a standard deviation of ±3.43. Most (63.4%) of the study participants had children living with them ().

Table 1 Socio-Demographic Characteristics of Participants in Selected Colleges of Addis Ababa, Ethiopia, May, 2021

Knowledge About COVID-19 Vaccination

This study reported that about 57.5% (95% CI: 52.5–62.3%) of the study participants had poor knowledge regarding COVID-19 disease. More than half (53%) of the study participants had heard of COVID-19 disease at first from social media. From all the WHO-recommended preventive protocols, most (80.6%), (81.8%), and (74.2%) of the study participants practiced hand washing, used antibiotics, and wore face masks consecutively. Most (69%) of the study participants knew that only AstraZeneca was given in Ethiopia ().

Table 2 Knowledge of the Study Participants About COVID-19 Vaccination in Selected Colleges of Addis Ababa, Ethiopia, May, 2021

Perceptions About COVID-19 Vaccination

Less than half (43%) of the study participants were afraid the first time they heard about COVID-19 disease. Less than half (44.2%) of the study participants perceived the importance of taking COVID-19 vaccination. Most (64%) of the study participants perceived that they would not get infected with COVID-19 ().

Table 3 Attitude About COVID-19 Disease and Vaccination Among Participants in Selected Colleges of Addis Ababa, Ethiopia, May, 2021

COVID-19 Vaccine Acceptance

The level of COVID-19 vaccine acceptance was 39.8% (95% CI: 35.0–44.7%). A quarter (25%) of the study participants thought it was the best preventive mechanism to prevent COVID-19. One-tenth (11%) of the study participants did not want to take the vaccine, worrying about the possible side effects ().

Table 4 COVID-19 Vaccination Acceptance of Participants in Selected Medical Colleges of Addis Ababa, Ethiopia, May, 2021

Predictors of COVID-19 Vaccine Acceptance

The bivariate logistic regression identified candidate variables for the multivariate logistic regression, at the p-value of 0.25 set as a cut-off point. Accordingly, nine variables fulfilled the candidacy for the multivariate logistic regression. After-effects of confounders were controlled in multivariate logistic regression, sex, living with an elderly person who was elder than 50 years old, and knowledge about the COVID-19 vaccine was statistically associated with COVID-19 vaccine acceptance.

The odds of vaccine acceptance was 53.7% higher among male participants as compared to the females (AOR: 0.463, 95% CI: 0.284–0.755, P<0.001). The odds of having had vaccine acceptance was 2.295 times higher among participants who lived with under-five years old children (AOR: 2.295; 95CI:1.416–3.721, P<0.05) and was 1.609 times higher among participants who lived with an elderly person (AOR: 1.609, 95% CI: 1.016–2.548, P<0.05). Similarly, the odds of vaccine acceptance was two folds higher among those participants with poor knowledge of COVID-19 compared to those with good knowledge (AOR: 2.187, 95% CI: 1.391–3.438, P < 0.001) ().

Table 5 Predictors of COVID-19 Vaccine Acceptance of in Selected Colleges Students of Addis Ababa, Ethiopia 2021

Discussions

In this study, the level of vaccine acceptance was 39.8%, which was consistent with the findings from 37.3% in Uganda,Citation27 37.4% in Jordan,Citation28 47% in BangladeshCitation30 and 47% in France.Citation31

The current finding was lower than the reports of 54.8% in Russia,Citation13 88.6% in China,Citation13 64.7% in Saudi Arabia,Citation32 67% in Indonesia,Citation11 75% in USCitation24 and 83% in Denmark.Citation31 Such variations might be attributed to the variations in the type of vaccine across the different countries and perception differences across the communities. Thus, the lower acceptance level in Ethiopia might be due to a limited option was available at the time of the investigation.

The level of vaccine acceptance in this study was higher than the finding from Republic of Congo that was 27.7%.Citation33 This variation might be linked to differences in study participant type across the studies.

In this study, being a male had a higher level of vaccine acceptance. The same was reported by a study from Uganda that being a male was associated with an increased level of vaccine acceptance.Citation27 A study from US college students reported that worrying about unknown side effects and unforeseen problems, vaccine cynicism, under evaluation for safety and political conservativeness to be predictors of vaccine hesitancy.Citation34

In this study, the level of vaccine acceptance was higher among participants who lived with the elderly and children of under-five years old. This was supported by another study.Citation35

The likelihood of vaccine acceptance was two folds higher among participants with poor knowledge about the COVID-19. Probably, participants with good knowledge of COVID-19 might have fear associated with vaccine type, efficacy, and fear associated with AstraZeneca. However, source of the information matters, participants with good knowledge had a higher tendency to vaccine acceptance.Citation36,Citation37

Conclusion and Recommendation

The level of vaccine acceptance among college students in Ethiopia was lower than necessary to achieve herd immunity. Sex, living with under-five children and elderly, knowledge were predictors of vaccine acceptance in the study settings. Policymakers, stakeholders, and concerned bodies were recommended to work on the identified predictors of COVID-19 vaccine acceptance.

Limitation of the Study

The study was a cross-sectional study, which had a nature of point observation and difficult to establish the temporal association between variables. The other limitation was difficulty of inferring to the community at large, as it was an institution-based study.

Abbreviations

AOR, adjusted odds ratio; COR, crude odds ratio; COVID-19, coronavirus disease 2019; WHO, World Health Organization.

Data Sharing Statement

A finding of this study was generated from the data collected and analyzed on the basis of stated methods and materials, hence all data were already available in the manuscript.

Ethics Approval and Consent to Participate

The study protocol was performed in accordance with the ethical principle. Ethical approval was obtained from ethics review Committee of Universal Medical and Business College. The ethics approval was given in accordance with the Declaration of Helsinki. The data collectors obtained written informed consent from all participants.

Consent for Publication

Consent for publication of the manuscript was not applicable due to the fact that there were no participant’s individual data videos or images.

Author Contributions

All authors contributed to data analysis, drafting or revising the article, have agreed on the journal to which the article was submitted, gave final approval of the version to be published, and agreed to be accountable for all aspects of the work.

Acknowledgments

The authors thank study participants for their willingness in taking part in the study.

Disclosure

The authors declare no conflicts of interest for this work.

Additional information

Funding

The authors received no specific funding for this work.

References

  • McKibbin W, Fernando R. The economic impact of COVID-19. In: Economics in the Time of COVID-19. 2020:45.
  • Yu Z, Razzaq A, Rehman A, Shah A, Jameel K, Mor RS. Disruption in global supply chain and socio-economic shocks: a lesson from COVID-19 for sustainable production and consumption. Oper Manag Res. 2021;1–16. doi:10.1007/s12063-021-00179-y
  • Das K. Impact of COVID-19 pandemic into solar energy generation sector. Available at SSRN 3580341; 2020.
  • Mofijur M, Fattah IR, Alam MA, et al. Impact of COVID-19 on the social, economic, environmental and energy domains: lessons learnt from a global pandemic. Sustain Prod Consum. 2020;26:343–359. doi:10.1016/j.spc.2020.10.016
  • Qiao S, Friedman DB, Tam CC, Zeng C, Li X. Vaccine acceptance among college students in South Carolina: do information sources and trust in information make a difference? MedRxiv. 2020. doi:10.1101/2020.12.02.20242982
  • Elmezayen AD, Al-Obaidi A, Şahin AT, Yelekçi K. Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J Biomol Struct Dyn. 2021;39(8):2980–2992. doi:10.1080/07391102.2020.1758791
  • Agarwal A, Mukherjee A, Kumar G, Chatterjee P, Bhatnagar T, Malhotra P. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial). BMJ. 2020;371:m3939.
  • Consortium WST. Repurposed antiviral drugs for COVID-19—interim WHO SOLIDARITY trial results. N Engl J Med. 2021;384(6):497–511.
  • Looi M-K. Covid-19: is a second wave hitting Europe? BMJ. 2020;371:m4113.
  • Wang J, Jing R, Lai X, et al. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. 2020;8(3):482. doi:10.3390/vaccines8030482
  • Harapan H, Wagner AL, Yufika A, et al. Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.00381
  • Saitoh A, Saitoh A, Katsuta T, et al. Effect of a vaccine information statement (VIS) on immunization status and parental knowledge, attitudes, and beliefs regarding infant immunization in Japan. Vaccine. 2020;38(50):8049–8054. doi:10.1016/j.vaccine.2020.10.049
  • Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–228. doi:10.1038/s41591-020-1124-9
  • Feleszko W, Lewulis P, Czarnecki A, Waszkiewicz P. Flattening the curve of COVID-19 vaccine rejection—A global overview. Available at SSRN; 2020.
  • Dubé E, Gagnon D, MacDonald N, Bocquier A, Peretti-Watel P, Verger P. Underlying factors impacting vaccine hesitancy in high income countries: a review of qualitative studies. Expert Rev Vaccines. 2018;17(11):989–1004. doi:10.1080/14760584.2018.1541406
  • Adamu AA, Essoh T-A, Adeyanju GC, et al. Drivers of hesitancy towards recommended childhood vaccines in African settings: a scoping review of literature from Kenya, Malawi and Ethiopia. Expert Rev Vaccines. 2021;20:1–11.
  • Peretti‐Watel P, Ward JK, Vergelys C, Bocquier A, Raude J, Verger P. ‘I think I made the right decision… I hope I’m not wrong’. Vaccine hesitancy, commitment and trust among parents of young children. Sociol Health Illn. 2019;41(6):1192–1206.
  • Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Sources and perceived credibility of vaccine-safety information for parents. Pediatrics. 2011;127(Supplement 1):S107–S12. doi:10.1542/peds.2010-1722P
  • Van Scoy LJ, Miller EL, Snyder B, et al. Knowledge, perceptions, and preferred information sources related to COVID-19 among central Pennsylvania adults early in the pandemic: a mixed methods cross-sectional survey. Ann Fam Med. 2021;19(4):293–301. doi:10.1370/afm.2674
  • Lin D, Friedman DB, Qiao S, Tam CC, Li X, Li X. Information uncertainty: a correlate for acute stress disorder during the COVID-19 outbreak in China. BMC Public Health. 2020;20(1):1–9. doi:10.1186/s12889-020-09952-3
  • Roy A, Singh AK, Mishra S, Chinnadurai A, Mitra A, Bakshi O. Mental health implications of COVID-19 pandemic and its response in India. Int J Soc Psychiatry. 2020;67(5):587–600. doi:10.1177/0020764020950769
  • Paluszek MM, Landry CA, Taylor S, Asmundson GJ. The psychological sequelae of the COVID-19 pandemic: psychological processes, current research ventures, and preparing for a postpandemic world. Behav Ther. 2020;43:158–163.
  • Van Scoy LJ, Snyder B, Miller EL, et al. Public anxiety and distrust due to perceived politicization and media sensationalism during early COVID-19 media messaging. J Commun Healthc. 2021;14(3):193–205. doi:10.1080/17538068.2021.1953934
  • Lennon RP, Small ML, Smith RA, et al. Unique predictors of intended uptake of a COVID-19 vaccine in adults living in a rural college town in the United States. Am J Health Promot. 2022;36(1):180–184. doi:10.1177/08901171211026132
  • Barello S, Nania T, Dellafiore F, Graffigna G, Caruso R. ‘Vaccine hesitancy’among university students in Italy during the COVID-19 pandemic. Eur J Epidemiol. 2020;35(8):781–783. doi:10.1007/s10654-020-00670-z
  • Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health. 2020. doi:10.1093/pubmed/fdaa230
  • Kanyike AM, Olum R, Kajjimu J, et al. Acceptance of the coronavirus disease-2019 vaccine among medical students in Uganda. Trop Med Health. 2021;49(1):1–11. doi:10.1186/s41182-021-00331-1
  • El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and attitudes toward COVID-19 vaccines: a cross-sectional study from Jordan. PLoS One. 2021;16(4):e0250555. doi:10.1371/journal.pone.0250555
  • Brewer NT, DeFrank JT, Gilkey MB. Anticipated regret and health behavior: a meta-analysis. Health Psychol. 2016;35(11):1264. doi:10.1037/hea0000294
  • Abedin M, Islam MA, Rahman FN, et al. Willingness to vaccinate against COVID-19 among Bangladeshi adults: understanding the strategies to optimize vaccination coverage. PLoS One. 2021;16(4):e0250495. doi:10.1371/journal.pone.0250495
  • Lindholt MF, Jørgensen F, Bor A, Petersen MB. Public acceptance of COVID-19 vaccines: cross-national evidence on levels and individual-level predictors using observational data. BMJ Open. 2021;11(6):e048172. doi:10.1136/bmjopen-2020-048172
  • Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidiscip Healthc. 2020;13:1657. doi:10.2147/JMDH.S276771
  • Nzaji MK, Ngombe LK, Mwamba GN, et al. Acceptability of vaccination against COVID-19 among healthcare workers in the Democratic Republic of the Congo. Pragmat Obs Res. 2020;11:103. doi:10.2147/POR.S271096
  • Small ML, Lennon R, Dziak J, Smith RA, Sommerville G, Bharti N. College Students’ COVID-19 Vaccine Beliefs and Intentions: implications for interventions. medRxiv. 2021. doi:10.1101/2021.05.28.21258008
  • Kerr JR, Schneider CR, Recchia G, et al. Predictors of COVID-19 vaccine acceptance across time and countries. MedRxiv. 2020. doi:10.1101/2020.12.09.20246439
  • Abebe H, Shitu S, Mose A. Understanding of COVID-19 vaccine knowledge, attitude, acceptance, and determinates of COVID-19 vaccine acceptance among adult population in Ethiopia. Infect Drug Resist. 2021;14:2015. doi:10.2147/IDR.S312116
  • Sakya SM, Scoy LJV, Garman JC, et al. The impact of COVID-19-related changes in media consumption on public knowledge: results of a cross-sectional survey of Pennsylvania adults. Curr Med Res Opin. 2021;37(6):911–915. doi:10.1080/03007995.2021.1901679